Identity-verification and risk-analytics data platform used by insurers, government and businesses to vet people.
Identity-verification and risk-analytics data platform used by insurers, government and businesses to vet people.
Sells access to its identity data and analytics as monthly or annual subscriptions and usage-based fees, rather than selling the data outright. FOREWARN, a safety tool for real-estate agents, is sold on a per-user basis, often through realtor associations. It was spun out of Cogint, now Fluent, in 2018.
Moat: narrow (data, scale). A large proprietary identity database is costly for smaller rivals to replicate.
Headquarters: Boca Raton, Florida, US · Founded: 2003 · Employees: 250
Size Red Violet (RDVT) is a United States Information Technology company (Packaged Software) with a market value of $1.14B, the 2151st largest of 3,085 United States companies the cockpit tracks. Shares closed at $70.99 on 18 Nov 2026.
Performance Over six months the shares gained 43.2%, against -21.4% for the median peer and -2.2% for the United States market (cap-weighted) — 4th highest of 20 in its peer set.
Growth Revenue grew 20.0% over the last twelve months (peer median +13.3%); the operating margin is 18.5% (peer median 2.1%).
Valuation It trades at 40.7× forward earnings against a peer median of 23.7× (3rd most expensive of 11).
Price implies For today's price to make sense, revenue must grow about 38% a year for seven years (Req g). Recent delivered growth is +21%, so the hurdle is +17 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 1.6 points below its cost of capital (13.7% WACC).
Backlog Backlog (remaining performance obligations) was $23.9M at 30 Sep 2026, up 21% on a year earlier — 0.2 years of trailing revenue. Backlog detail →
Next results Next results expected around 10 Mar 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | $104M | $90.3M | $75.2M | $60.2M | $53.3M |
| Revenue growth | — | +20% | +25% | +13% | — |
| Gross profit | $76.9M | $64.9M | $51.6M | $38.8M | $34.4M |
| EBITDA | $30.4M | $23.8M | $17.5M | $10.9M | $7.58M |
| Net income | $17.6M | $13.2M | $7.00M | $13.5M | $616,000 |
| Free cash flow | $36.2M | $28.8M | $23.8M | $14.9M | $12.1M |
| Capital expenditure | $13.9M | $11.2M | $9.57M | $9.15M | $8.83M |
| Total debt | $2.57M | $2.79M | $2.00M | $2.57M | $1.29M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Red Violet RDVT | $1.14B | +43% | +20% | 18% | 40.7× | 38.3% |
| TransUnion TRU | $14.5B | +10% | +13% | 15% | 14.8× | 19.5% |
| Thomson Reuters TRI.TO | $45.0B | +27% | +6% | 26% | 23.7× | 2.1% |
| Verisk Analytics VRSK | $26.0B | +19% | +5% | 45% | 24.0× | 5.0% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | RDVT | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -6.9% | -10.0% | 7th highest of 21 |
| 6-month return | +43.2% | -21.4% | 4th highest of 20 |
| Distance from 52-week high | -14.6% | -46.9% | 4th highest of 21 |
| Revenue growth (TTM) | +20.0% | +13.3% | 9th highest of 21 |
| Operating margin | 18.5% | 2.1% | 4th highest of 21 |
| Forward P/E | 40.7× | 23.7× | 3rd most expensive of 11 |
| Growth the price implies (Req g, 7 yrs) | 38.3% | 14.8% | 3rd most demanding of 13 |
| Growth delivered (Del g) | +21.1% | +15.9% | 5th highest of 13 |
| Hurdle (Req g minus delivered) | +17.2 pp | +3.7 pp | 3rd most demanding of 13 |
| ROIC minus cost of capital | -1.6 pp | -6.6 pp | 8th highest of 19 |
| EV / EBITDA | 34.2× | 12.0× | 2nd most expensive of 7 |
| Net debt / EBITDA | -3.4× | -1.9× | 4th least indebted of 9 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Red Violet RDVT | United States | $1.14B | +43% | +20% | 18% | 40.7× | 38.3% | +21.1% |
| WeRide 0800.HK | Hong Kong | $1.14B | -44% | +109% | -221% | n/a | n/a | n/a |
| Vitec Software VIT-B.ST | Sweden | $1.15B | +5% | +6% | 21% | 23.4× | 3.7% | +22.6% |
| Infomart 2492.T | Japan | $1.15B | +78% | +11% | 19% | 61.1× | 12.6% | +16.5% |
| SHIFT UP 462870.KS | South Korea | $1.13B | -21% | -27% | 50% | 14.8× | -12.0% | +59.7% |
| Genimous Technology 000676.SZ | China | $1.15B | -11% | +3% | 6% | n/a | 11.8% | -17.5% |
| Fengzhushou 301382.SZ | China | $1.16B | -42% | +28% | 8% | n/a | n/a | n/a |
| Wuxi Boton Technology 300031.SZ | China | $1.11B | -20% | +22% | 2% | 24.1× | 23.6% | +5.6% |
| Riskified RSKD | United States | $1.11B | +100% | +18% | -3% | 24.4× | 12.0% | +15.3% |
| Hangzhou Diagens Biotechnology 2526.HK | Hong Kong | $1.11B | -67% | +134% | -49% | n/a | n/a | n/a |
| Bingo Software 688227.SS | China | $1.17B | -29% | -7% | -11% | n/a | n/a | n/a |
| Baige Online Digital Technology 2672.HK | Hong Kong | $1.18B | n/a | +34% | -3% | n/a | 53.3% | +41.4% |
| freee K.K 4478.T | Japan | $1.19B | +50% | +26% | 4% | 55.3× | 41.6% | +32.8% |
| Richinfo Technology 300634.SZ | China | $1.19B | -24% | -11% | 10% | 28.7× | 19.2% | +19.9% |
| Transwarp Technology Shanghai 688031.SS | China | $1.09B | -51% | +27% | -49% | n/a | n/a | n/a |
| Merit Interactive 300766.SZ | China | $1.08B | -36% | +30% | -2% | n/a | n/a | n/a |
| Chinasoft International 0354.HK | Hong Kong | $1.07B | -5% | +3% | 2% | 11.2× | 16.9% | +3.1% |
| Datang Telecom Technology 600198.SS | China | $1.21B | -34% | -11% | -30% | n/a | n/a | n/a |
| Wondershare Technology 300624.SZ | China | $1.21B | -34% | -8% | -12% | n/a | n/a | n/a |
| InnovAge INNV | United States | $1.22B | +19% | +15% | 8% | 19.7× | -6.5% | +9.2% |
| Cyient CYIENT.NS | India | $1.22B | +20% | +10% | 9% | 19.8× | 20.1% | +12.0% |
Red Violet reported $23.9M of remaining performance obligations at 30 Sep 2026, up 21% from a year earlier and up 0% from the previous quarter. That is 0.2 years of trailing revenue already under contract. Book-to-bill last quarter: 1.00.